Conmed (CNMD) Equity Average (2011 - 2026)

Conmed (CNMD) has 16 years of Equity Average data on file, last reported at $1.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 5.69% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 5.69% YoY), and the FY2025 full-year result was $997.9 million, up 11.07% from the prior year.
• Equity Average for Q1 2026 stood at $1.0 billion, roughly flat from $1.0 billion in the prior quarter.
• Across five years, Equity Average topped out at $1.0 billion in Q1 2026 and bottomed at $694.7 million in Q3 2022.
• The 5-year median for Equity Average is $844.4 million (2024), against an average of $861.4 million.
• The widest annual swing landed in 2022, when Equity Average slipped 7.39%; it then advanced 16.26% in 2024.
• A 5-year view of Equity Average shows it stood at $730.9 million in 2022, then gained by 11.53% to $815.2 million in 2023, then advanced by 16.26% to $947.8 million in 2024, then climbed by 7.69% to $1.0 billion in 2025, then increased by 0.46% to $1.0 billion in 2026.
• The last three Equity Average figures came in at $1.0 billion (Q1 2026), $1.0 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.

Peer Comparison